Skip to main content
Clinical Trials/DRKS00017137
DRKS00017137
Completed
Not Applicable

ong-term clinical outcome after reconstruction of atrophied alveolar ridge using collagenated xenogeneic bone block (CXBB) or autogenous bone block (ABB). Follow-up of randomized controlled clinical investigation 10828-021.

Geistlich Pharma AG0 sites51 target enrollmentMay 29, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Survival of the implants as well as the bone tissue and soft tissue at the augmented area
Sponsor
Geistlich Pharma AG
Enrollment
51
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 29, 2019
End Date
October 18, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Successful atrophied alveolar ridge reconstruction in clinical investigation 10828\-021
  • \- Implant placement at restored site
  • \- Implant loading
  • \- Written informed consent
  • \- Final impression taken at the delivery of the implant\-supported restoration (Visit 10 in study No. 10828\-021\) (Amendment No.1\)

Exclusion Criteria

  • \- Newly diagnosed diseases interfering with bone metabolism
  • \- Severe trauma to implant site
  • \- Orthodontic treatment in the same quadrant
  • \- Participation in a clinical study interfering with the objective of this non\-interventional long\-term follow\-up observation

Outcomes

Primary Outcomes

Not specified

Similar Trials